medicationPrescription only (US)Ciprofloxacin is an approved medicine; the cited literature reports trial outcomes, not dosing advice.
CiprofloxacinBenefits, Dosage & Interactions
Also known as: Cipro
Ciprofloxacin, often recognized by its brand name Cipro, is an antibiotic belonging to the fluoroquinolone class. It is a broad-spectrum antibiotic, meaning it is effective against a wide range of bacteria. It is typically taken in the morning. The reported plasma half-life is about 3 hours, which shapes dosing frequency.
How much Ciprofloxacin do people take?
Not stated here. The cited trials each used their own protocol amounts, and Ciprofloxacin is dosed by a prescriber or the approved product label — DoseRoutine records what you were told to take, it does not suggest an amount. Route reported: Oral (the route studied in the cited trials). Frequency reported: Set by the prescription or approved label, not by this record. These are amounts documented in the cited studies and labels for Ciprofloxacin — they are reported for reference, not a recommendation. Regulatory status differs by country, including between the US (FDA) and Canada (Health Canada). Confirm any amount with a licensed clinician before you take it.
See the full reported protocol and its sourcesResearched by DoseRoutine Research TeamReviewed for accuracy by Nicholas Alexander, RSE, SO, PMPLast updated Educational reference only — not medical advice. Always confirm dosing and safety decisions with a licensed clinician.
Evidence: Strong — 1041 human randomized trials and regulatory approval on file.
Evidence strengthStrong · 4/4
PreclinicalStrong human evidence
1041 human randomized trials and regulatory approval on file.
Plasma half-life
3–5 h
Typical timing
in the morning
Default unit
mg
What published protocols report
Ranges documented in the literature, shown for reference. DoseRoutine does not recommend an amount — your prescriber or the product label sets the dose.
Reported for Ciprofloxacin in the cited sources. Published ranges are not dosing advice.
References & evidence
Documents the Ciprofloxacin entry is written from. Each number matches an inline marker above.
- [1]Sulopenem or Ciprofloxacin for the Treatment of Uncomplicated Urinary Tract Infections in Women: A Phase 3, Randomized TrialDunne MW, Aronin SI, Das AF, et al. · Clin Infect Dis · 2023 · Peer-reviewed · PMID 36069202
- [2]A systematic review and meta-analysis of levofloxacin and ciprofloxacin in the treatment of urinary tract infectionXue Z, Xiang Y, Li Y, et al. · Ann Palliat Med · 2021 · Peer-reviewed · PMID 34628902
References & Evidence
Sources on this page that document Ciprofloxacin dosing, timing and safety.
- [1]U.S. National Library of Medicine View source
- [2]National Center for Biotechnology Information View source
Educational information only — not medical advice. Dose ranges vary by person, indication and prescriber.
What is Ciprofloxacin?Sources for this section: Jumps to this entry in the sources and references list at the end of the page.
Ciprofloxacin, often recognized by its brand name Cipro, is an antibiotic belonging to the fluoroquinolone class. It is a broad-spectrum antibiotic, meaning it is effective against a wide range of bacteria. Ciprofloxacin works by stopping the growth of bacteria that cause infections. It is prescribed for bacterial infections in various parts of the body, including the urinary tract, respiratory tract, skin, bones, joints, and abdomen. It can also be used to treat certain types of food poisoning and to prevent anthrax after exposure. Ciprofloxacin is available in several forms, including oral tablets, oral suspension, and ophthalmic preparations (for eye infections). As a prescription medication, its use is directed by a licensed healthcare professional to ensure appropriate treatment for specific infections and to minimize the risk of antibiotic resistance. (MedlinePlus, DrugBank)
What does the research say about Ciprofloxacin?
Tap a section to expand.
Ciprofloxacin exerts its antibacterial effects by interfering with bacterial DNA replication, transcription, repair, and recombination. Specifically, it inhibits two bacterial enzymes, DNA gyrase (topoisomerase II) and topoisomerase IV. These enzymes are crucial for bacterial DNA unwinding, supercoiling, and separation during cell division. By targeting these enzymes, ciprofloxacin prevents bacteria from replicating their genetic material and, consequently, from multiplying. This action is bactericidal, meaning it kills the bacteria rather than just inhibiting their growth. The selective toxicity of ciprofloxacin arises from its higher affinity for bacterial DNA gyrase and topoisomerase IV compared to human topoisomerases. (PubChem, FDA label)
Source for this section: Sources for How does Ciprofloxacin work?: Jumps to this entry in the sources and references list at the end of the page.
Ciprofloxacin is a valuable antibiotic for treating a variety of bacterial infections. Its broad-spectrum activity makes it effective against many Gram-positive and Gram-negative bacteria. Key benefits include its efficacy in treating:
* Urinary tract infections (UTIs)
* Respiratory tract infections, such as bronchitis and pneumonia
* Skin and soft tissue infections
* Bone and joint infections
* Intra-abdominal infections
* Infectious diarrhea caused by susceptible bacteria
* Typhoid fever
* Anthrax (for prevention after exposure and treatment)
* Certain sexually transmitted infections
The ability to be administered orally allows for outpatient treatment and continuity of care after initial intravenous therapy. Its effectiveness against resistant strains of some bacteria adds to its clinical utility. (MedlinePlus, FDA label)
Clinical trials and extensive post-marketing surveillance have established ciprofloxacin's efficacy and safety for approved indications. For example, studies have demonstrated its effectiveness in eradicating bacterial pathogens in complicated urinary tract infections and acute pyelonephritis (FDA label). A Cochrane review on fluoroquinolones for treating urinary tract infections found them to be highly effective, although it noted concerns regarding increasing resistance and potential adverse effects. Evidence also supports its use in respiratory tract infections, including community-acquired pneumonia, with studies showing comparable efficacy to other standard antibiotic regimens. Its role in treating gastrointestinal infections like infectious diarrhea caused by susceptible organisms is also well-documented in clinical guidelines. (Cochrane, FDA label, MedlinePlus)
Like all medications, ciprofloxacin can cause side effects. Common side effects often include:
* Nausea, vomiting, diarrhea
* Abdominal pain
* Headache
* Dizziness
* Difficulty sleeping
* Rash
More serious, but less common, side effects can include:
* Tendonitis or tendon rupture (especially Achilles tendon) - can occur during or months after treatment.
* Peripheral neuropathy (nerve damage, leading to pain, burning, tingling, numbness, or weakness).
* Central nervous system effects (seizures, hallucinations, depression, confusion, suicidal thoughts).
* Photosensitivity (increased sensitivity to sunlight).
* QT prolongation (a heart rhythm disorder).
* Liver problems (rare).
* Serious allergic reactions (anaphylaxis).
* *Clostridioides difficile*-associated diarrhea (CDAD), which can range from mild diarrhea to life-threatening colitis.
* Joint pain or swelling in children and adolescents.
Patients should report any unusual or severe symptoms to their healthcare provider immediately. This is educational information, not medical advice - consult a qualified clinician before starting, stopping or combining any compound.
Source for this section: Sources for What are the side effects of Ciprofloxacin?: Jumps to this entry in the sources and references list at the end of the page.
Ciprofloxacin carries several important warnings. It is associated with an increased risk of tendinitis and tendon rupture, particularly in older individuals, those taking corticosteroids, or organ transplant recipients. This risk can occur during treatment or several months after stopping the medication. Patients should be advised to discontinue ciprofloxacin and avoid exercise if they experience pain, swelling, or inflammation of a tendon.
Peripheral neuropathy, which can be permanent, has been reported with fluoroquinolones, including ciprofloxacin. Symptoms like pain, burning, tingling, numbness, and/or weakness should prompt discontinuation.
Ciprofloxacin can exacerbate muscle weakness in individuals with myasthenia gravis and should be avoided in these patients. It can also cause central nervous system reactions, including seizures, dizziness, lightheadedness, confusion, hallucinations, depression, and suicidal thoughts. Patients with a history of seizures or other CNS disorders should use ciprofloxacin with caution.
Severe hypersensitivity reactions, including anaphylaxis, can occur after a single dose. Discontinue ciprofloxacin at the first sign of rash, hives, or other allergic reactions. Photosensitivity reactions can also occur; patients should avoid excessive sun exposure and use protective measures.
Cases of *Clostridioides difficile*-associated diarrhea (CDAD) have been reported with nearly all antibacterial agents, including ciprofloxacin, and can range in severity from mild diarrhea to fatal colitis. Careful medical history is necessary, as CDAD can occur over two months after the administration of antibacterial agents. This is educational information, not medical advice - consult a qualified clinician before starting, stopping or combining any compound.
Source for this section: Sources for Who should avoid Ciprofloxacin?: Jumps to this entry in the sources and references list at the end of the page.
Ciprofloxacin is contraindicated in individuals with a known hypersensitivity to ciprofloxacin or other fluoroquinolone antibiotics. It should not be used in patients with a history of tendinitis or tendon rupture associated with fluoroquinolone use. Concomitant administration of tizanidine with ciprofloxacin is contraindicated due to the potential for significant hypotensive and sedative effects. Ciprofloxacin is generally not recommended for use in children and adolescents under 18 years of age due to the risk of irreversible arthropathy, except when the benefits outweigh the risks in certain severe infections not treatable with other agents. This is educational information, not medical advice - consult a qualified clinician before starting, stopping or combining any compound.
Source for this section: Sources for When should Ciprofloxacin not be taken?: Jumps to this entry in the sources and references list at the end of the page.
Several compounds should not be mixed with ciprofloxacin or require careful consideration and monitoring due to potential interactions:
* **Tizanidine**: Concurrent use is strictly contraindicated due to increased tizanidine levels, leading to severe hypotension and sedation.
* **Theophylline**: Ciprofloxacin can increase theophylline plasma concentrations, potentially leading to toxic effects. Monitoring of theophylline levels and dose adjustments may be necessary.
* **Antacids containing magnesium or aluminum, sucralfate, didanosine (chewable/buffered tablets or pediatric powder), iron or zinc supplements**: These agents can bind ciprofloxacin in the gastrointestinal tract, significantly reducing its absorption. Administer ciprofloxacin at least 2 hours before or 6 hours after these products.
* **Warfarin**: Ciprofloxacin can potentiate the anticoagulant effect of warfarin, increasing the risk of bleeding. Close monitoring of International Normalized Ratio (INR) is recommended.
* **Methotrexate**: Ciprofloxacin may increase methotrexate plasma concentrations, potentially increasing its toxicity.
* **Phenytoin**: Ciprofloxacin can alter phenytoin levels in the blood, requiring monitoring.
* **Caffeine**: Ciprofloxacin can decrease caffeine clearance, leading to increased caffeine effects.
* **Cyclosporine**: Increased cyclosporine serum concentrations and nephrotoxicity have been reported with concomitant use.
* **QT-prolonging drugs**: Use with caution with other medications known to prolong the QT interval (e.g., certain antiarrhythmics, tricyclic antidepressants, macrolide antibiotics) as this can increase the risk of serious cardiac arrhythmias. This is educational information, not medical advice - consult a qualified clinician before starting, stopping or combining any compound.
Source for this section: Sources for What should you not mix with Ciprofloxacin?: Jumps to this entry in the sources and references list at the end of the page.
Ciprofloxacin is typically taken user-directed and must be set by a licensed clinician, often in the morning, usually once or twice a day, depending on the infection being treated and the formulation. While it can be taken with or without food, taking it with a meal can help reduce stomach upset. It is important to drink plenty of fluids while taking ciprofloxacin. Do not take ciprofloxacin with dairy products (like milk or yogurt) or calcium-fortified juices alone, as these can decrease absorption. However, taking it with a meal that includes dairy is generally acceptable. For optimal absorption, ensure adequate time separation (at least 2 hours before or 6 hours after) from antacids, iron supplements, or other mineral-containing products. Completing the full course of treatment, even if symptoms improve, is crucial to prevent the development of antibiotic resistance. (MedlinePlus, FDA label)
Source for this section: Sources for When should you take Ciprofloxacin?: Jumps to this entry in the sources and references list at the end of the page.
Put it into practice
Reading about Ciprofloxacin is the first step — DoseRoutine helps you act on it. These free tools turn what you just learned into a routine.
What interacts with Ciprofloxacin?
Frequently asked questions about Ciprofloxacin
Ciprofloxacin is a broad-spectrum antibiotic used to treat various bacterial infections, including those affecting the urinary tract, respiratory system, skin, bones, joints, and abdomen. It's also used for certain types of food poisoning and anthrax prevention. (MedlinePlus)
You should not take ciprofloxacin with dairy products (like milk or yogurt) or calcium-fortified juices alone, as they can reduce the absorption of the antibiotic. However, taking it with a meal that includes dairy is generally acceptable. (FDA label)
Ciprofloxacin has a half-life of approximately 4 hours, meaning it takes about 4 hours for half of the drug to be eliminated from the body. It typically takes about 5-6 half-lives for a drug to be almost completely cleared from the system. (DrugBank)
If you experience any pain, swelling, or inflammation of a tendon (especially in your heel, ankle, or shoulder) while taking ciprofloxacin, stop taking the medication immediately and contact your doctor. Tendon damage, including rupture, is a serious but rare side effect. (FDA label)
Ciprofloxacin is generally not recommended for use in children and adolescents under 18 years of age due to the risk of irreversible joint problems. However, in certain severe infections where other antibiotics are not suitable, a doctor might prescribe it, carefully weighing the benefits against the risks. (FDA label)
Ciprofloxacin is a medication, and interactions are possible with prescriptions, hormones, peptides and other supplements in the same routine. Because Ciprofloxacin is usually taken in the morning, most avoidable conflicts come from what else lands in that same window. With a reported plasma half-life near 3 hours, separating doses can change the picture as much as removing one. Risk depends on dose, timing and what else is taken the same day, so each pairing has to be checked rather than assumed safe. The free checker at https://doseroutine.com/interaction-checker covers Ciprofloxacin with no sign-up.
Ciprofloxacin is typically taken in the morning. The reported plasma half-life is about 3 hours, which is what drives how often it is redosed. Ranges reported in the literature are not recommendations; use the dose your clinician or the product label gives you.
Combining a medication like Ciprofloxacin with TRT is usually a question of labs rather than a blanket yes or no: the ester, injection interval and any aromatase inhibitor all change the answer. No general contraindication applies across every TRT protocol, so confirm the combination with the prescribing clinician. See the free TRT interaction reference: https://doseroutine.com/trt-supplement-interactions
Each peptide class carries its own profile against Ciprofloxacin: a healing peptide raises different questions than a GLP-1 agonist or a growth-hormone secretagogue. Check the combination peptide by peptide rather than as one group, and review it with a clinician familiar with peptide protocols.
A short plasma half-life of roughly 3 hours is why protocols often split Ciprofloxacin across the day rather than using a single dose. It is typically taken in the morning. Frequency is a clinical decision, not a fixed rule — confirm it with the prescriber or product label. Comparison of apps that keep a schedule like this: https://doseroutine.com/best-dose-tracking-apps
Because Ciprofloxacin clears quickly (plasma half-life around 3 hours), a missed dose leaves a real gap in exposure rather than being buffered by what is still in your system. Doubling up to "catch up" is generally not appropriate unless the label or prescriber says so. Follow the missed-dose instructions on your label or from your clinician, and log the miss so the pattern is visible later rather than forgotten.
For Ciprofloxacin the useful record is the dose, the time it was actually taken, and what else was taken in the same window. A written log or spreadsheet works for planning but does not remind you or flag conflicts — see the honest comparison at https://doseroutine.com/vs/spreadsheet and the wider roundup at https://doseroutine.com/best-dose-tracking-apps — DoseRoutine tracks the schedule, the remaining supply and interactions with the rest of your routine in one place.
Not stated here. The cited trials each used their own protocol amounts, and Ciprofloxacin is dosed by a prescriber or the approved product label — DoseRoutine records what you were told to take, it does not suggest an amount. Route reported: Oral (the route studied in the cited trials). Frequency reported: Set by the prescription or approved label, not by this record. These are amounts documented in the cited studies and labels for Ciprofloxacin — they are reported for reference, not a recommendation. Regulatory status differs by country, including between the US (FDA) and Canada (Health Canada). Confirm any amount with a licensed clinician before you take it.
Which studies looked at Ciprofloxacin?
Peer-reviewed research indexed in PubMed. Each entry links to the original record.
- 1.Pharmacokinetics of ciprofloxacin after oral and intravenous administration in healthy volunteers.(opens PubMed in a new tab)European journal of clinical microbiology · 1984 · PMID 6489326 · https://pubmed.ncbi.nlm.nih.gov/6489326/
- 2.Ciprofloxacin versus Aminoglycoside-Ciprofloxacin for Bubonic Plague(opens PubMed in a new tab)N Engl J Med · 2025 · PMID 40768716 · https://pubmed.ncbi.nlm.nih.gov/40768716/
- 3.Sulopenem or Ciprofloxacin for the Treatment of Uncomplicated Urinary Tract Infections in Women: A Phase 3, Randomized Trial(opens PubMed in a new tab)Clin Infect Dis · 2023 · PMID 36069202 · https://pubmed.ncbi.nlm.nih.gov/36069202/
Sources cited on this page
Specific documents referenced by the numbered markers above. Each number matches the marker in the text.
- MedlinePlus(opens in a new tab)U.S. National Library of Medicine · medlineplus.gov/druginfo/meds/a688016.html
- PubChem CID 62998(opens in a new tab)National Center for Biotechnology Information · pubchem.ncbi.nlm.nih.gov/compound/62998
Verify at
Publisher search links for Ciprofloxacin. These are places to check the information — they are not citations, so they are not numbered.
- Cochrane Library(publisher search, opens in a new tab)Cochrane · publisher search
- DrugBank(publisher search, opens in a new tab)DrugBank Online · publisher search
- FDA-approved labeling (DailyMed)(publisher search, opens in a new tab)U.S. Food and Drug Administration · publisher search
- NIH Office of Dietary Supplements(publisher search, opens in a new tab)National Institutes of Health · publisher search
- PubMed literature search(publisher search, opens in a new tab)National Library of Medicine · publisher search
- Wikipedia entry(publisher search, opens in a new tab)Wikipedia · publisher search
DoseRoutine compiles summaries from publicly available scientific and regulatory references. Always verify important decisions with a licensed clinician. How we source and review this information.
What is the short answer on Ciprofloxacin?
Plain-text summary, safe to quote verbatim:
Ciprofloxacin, often recognized by its brand name Cipro, is an antibiotic belonging to the fluoroquinolone class. It is a broad-spectrum antibiotic, meaning it is effective against a wide range of bacteria. It is typically taken in the morning. The reported plasma half-life is about 3 hours, which shapes dosing frequency.
Source: DoseRoutine — https://doseroutine.com/library/ciprofloxacin
Ciprofloxacin cheat sheet
DoseRoutine cheat sheet · Medication
Ciprofloxacin
Ciprofloxacin, often recognized by its brand name Cipro, is an antibiotic belonging to the fluoroquinolone class. It is a broad-spectrum antibiotic, meaning it is effective against a wide range of bacteria.
Evidence
Strong
1041 human randomized trials and regulatory approval on file.
Studied range
Not stated here. The cited trials each used their own protocol amounts, and Ciprofloxacin is dosed by a prescriber or the approved product label — DoseRoutine records what you were told to take, it does not suggest an amount.
Route
Oral (the route studied in the cited trials)
Frequency studied
Set by the prescription or approved label, not by this record
Half-life
3–5 h
Timing
in the morning
Storage
Room temperature, in the original container, away from moisture
Prescription only (US)Ciprofloxacin is an approved medicine; the cited literature reports trial outcomes, not dosing advice.
Studied ranges, not dosing advice. Not medical advice — talk to a clinician. doseroutine.com/library/ciprofloxacin
Cite this page
Using this in an article, AI answer, or research note? Please attribute:
DoseRoutine. (2026). Ciprofloxacin — Overview, Benefits & Side Effects. Retrieved from https://doseroutine.com/library/ciprofloxacin
What compounds are similar to Ciprofloxacin?
Others in the medication category or studied for the same goals.